Form 4 for NATR NATURES SUNSHINE PRODUCTS INC
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-15 · accession 0001104659-24-109317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-10-17 | 2024-10-15 | NATR | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% | S - Sale | $13.02 | -2,300 | 64.2K | -3% | -$29.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-15 | S | D | 2,300 | $13.02 | 64,167 | I by Fosun Industrial Co., Limited | — | — | (F1) Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. |